Dezhan Healthcare Company Limited (SHE:000813)
China · Delayed Price · Currency is CNY 3.620
+0.040 (1.12%)
Apr 29, 2026, 3:04 PM CST
Dezhan Healthcare Company Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Revenue | 396.16 | 396.81 | 465.59 | 496.37 | 570.74 | 729.81 |
Other Revenue | - | - | 0.9 | 1.72 | 0.11 | 4.67 |
| 396.16 | 396.81 | 466.49 | 498.09 | 570.86 | 734.48 | |
Revenue Growth (YoY) | -12.84% | -14.94% | -6.35% | -12.75% | -22.28% | -23.72% |
Cost of Revenue | 188 | 173.98 | 170.39 | 223.13 | 359.44 | 261.42 |
Gross Profit | 208.15 | 222.83 | 296.09 | 274.96 | 211.41 | 473.06 |
Selling, General & Admin | 297.98 | 304.15 | 293.26 | 263.26 | 303.62 | 342.89 |
Research & Development | 89.06 | 82.28 | 68.37 | 51.1 | 51.49 | 67.06 |
Other Operating Expenses | 11.58 | 9.94 | 10.54 | 11.47 | 9.46 | 12.3 |
Operating Expenses | 398.62 | 396.36 | 378.02 | 330.64 | 364.51 | 423.29 |
Operating Income | -190.47 | -173.53 | -81.92 | -55.69 | -153.1 | 49.77 |
Interest Expense | - | - | -0.37 | -0.37 | -0.71 | -0.65 |
Interest & Investment Income | 4.82 | - | 66.36 | 148.32 | 86.8 | 84.82 |
Currency Exchange Gain (Loss) | - | - | 0 | -1.87 | -3.46 | -0.23 |
Other Non Operating Income (Expenses) | -41.95 | -40.72 | -10.28 | -10.95 | -9.94 | -164.68 |
EBT Excluding Unusual Items | -223.63 | -214.26 | -26.21 | 79.45 | -80.4 | -30.97 |
Impairment of Goodwill | - | - | - | - | - | -14.2 |
Gain (Loss) on Sale of Investments | -27.76 | -27.79 | -19.87 | - | - | - |
Gain (Loss) on Sale of Assets | 1.37 | 1.38 | -0.02 | -0.03 | 0.33 | 0.02 |
Asset Writedown | -185.73 | -179.76 | -1.56 | -7.23 | -41.98 | -0.31 |
Other Unusual Items | - | - | 3.55 | 9.65 | 0.98 | 8.36 |
Pretax Income | -435.75 | -420.42 | -44.11 | 81.84 | -121.08 | -37.11 |
Income Tax Expense | 0.07 | 1.5 | -1.89 | 27.6 | 32.38 | 59.09 |
Earnings From Continuing Operations | -435.82 | -421.93 | -42.22 | 54.24 | -153.46 | -96.2 |
Minority Interest in Earnings | 78.09 | 76.51 | 21.81 | 29.07 | 106.51 | 38.62 |
Net Income | -357.73 | -345.42 | -20.41 | 83.31 | -46.95 | -57.58 |
Net Income to Common | -357.73 | -345.42 | -20.41 | 83.31 | -46.95 | -57.58 |
Shares Outstanding (Basic) | 2,108 | 2,115 | 2,149 | 2,181 | 2,215 | 2,241 |
Shares Outstanding (Diluted) | 2,108 | 2,115 | 2,149 | 2,181 | 2,215 | 2,241 |
Shares Change (YoY) | -1.56% | -1.56% | -1.48% | -1.52% | -1.15% | 0.95% |
EPS (Basic) | -0.17 | -0.16 | -0.01 | 0.04 | -0.02 | -0.03 |
EPS (Diluted) | -0.17 | -0.16 | -0.01 | 0.04 | -0.02 | -0.03 |
Free Cash Flow | -276.37 | -231.27 | -181.14 | -31.86 | 94.16 | -84.51 |
Free Cash Flow Per Share | -0.13 | -0.11 | -0.08 | -0.01 | 0.04 | -0.04 |
Gross Margin | 52.54% | 56.16% | 63.47% | 55.20% | 37.04% | 64.41% |
Operating Margin | -48.08% | -43.73% | -17.56% | -11.18% | -26.82% | 6.78% |
Profit Margin | -90.30% | -87.05% | -4.38% | 16.73% | -8.22% | -7.84% |
Free Cash Flow Margin | -69.76% | -58.28% | -38.83% | -6.40% | 16.50% | -11.51% |
EBITDA | -105.57 | -89.49 | -1.32 | 25.7 | -64.27 | 127.85 |
EBITDA Margin | -26.65% | -22.55% | -0.28% | 5.16% | -11.26% | 17.41% |
D&A For EBITDA | 84.91 | 84.05 | 80.61 | 81.39 | 88.83 | 78.08 |
EBIT | -190.47 | -173.53 | -81.92 | -55.69 | -153.1 | 49.77 |
EBIT Margin | -48.08% | -43.73% | -17.56% | -11.18% | -26.82% | 6.78% |
Effective Tax Rate | - | - | - | 33.72% | - | - |
Revenue as Reported | - | - | 466.49 | 498.09 | 570.86 | 734.48 |
Advertising Expenses | - | - | 46.35 | 52.54 | 108.97 | 148.13 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.